As of Nov 19, 2026, 1 of 1 active firms rate PYPD a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
PYPD EPS & revenue forecast
EPS · NEXT QUARTER
$-0.24
Range $-0.35 – $-0.18 · 3 analysts · -31% YoY
Next period, 3 analysts expect PolyPid to earn $-0.24 a share (range $-0.35 – $-0.18), versus $-0.35 a year earlier. Full-year consensus is $-0.98, growing to $-0.94 the year after.
REVENUE · NEXT QUARTER
$1.2M
Range $355.0K – $2.7M · 3 analysts
Revenue is expected to reach $1.2M (range $355.0K – $2.7M). Full-year consensus is $9.1M, rising to $9.7M next year.
Top analysts covering PolyPid
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PYPD.
#1
Chase Knickerbocker
Craig-Hallum · Rank #17
Buy
$12.00+83.5% to target
Overall win rate
61%
+ Follow
#2
Roy Buchanan
JMP Securities · Rank #176
Buy
$14.00+114.1% to target
Overall win rate
47%
+ Follow
#3
BF
Brandon Folkes
HC Wainwright & Co. · Rank #402
Buy
$13.00+98.8% to target
Overall win rate
38%
+ Follow
#4
Raghuram Selvaraju
HC Wainwright & Co. · Rank #423
Buy
$11.00+68.2% to target
Overall win rate
36%
+ Follow
#5
Boobalan Pachaiyappan
Roth Capital
Buy
$9.00+37.6% to target
Coverage
—
+ Follow
PYPD stock forecast FAQ
What is PYPD's average 12-month price target?+
The 1 active firms with a live target average $13.00 for PolyPid over the next 12 months, ranging from a $13.00 high to a $13.00 low, as of Nov 19, 2026.
Is PYPD stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 1 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
How many active Wall Street firms cover PYPD?+
1 active firms have a recognized rating on PolyPid as of Nov 19, 2026, and 1 active firms carry a live 12-month price target.
Who is the most accurate analyst covering PYPD?+
Among analysts who currently cover PYPD, Chase Knickerbocker of Craig-Hallum has the strongest overall Quantellect track record (Rank #17). Their current call is Buy with a $12.00 target.
What is PolyPid's projected EPS for next quarter?+
The consensus estimate is $-0.24 per share (range $-0.35 – $-0.18) across 3 analysts. Full-year EPS is projected at $-0.98, rising to $-0.94 the following year.
How much revenue is PolyPid expected to report next quarter?+
Consensus revenue is $1.2M (range $355.0K – $2.7M). Full-year revenue is projected at $9.1M, growing to $9.7M next year.
Have analysts been upgrading or downgrading PYPD lately?+
As of Nov 19, 2026, 1 of 1 active firms rate PYPD a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PYPD calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.